US4057059A
(en)
*
|
1975-07-29 |
1977-11-08 |
Oklahoma State University |
Intermittent positive pressure breathing device
|
US4060078A
(en)
*
|
1975-08-18 |
1977-11-29 |
Bird F M |
Ventilator and method
|
US4003377A
(en)
*
|
1975-08-21 |
1977-01-18 |
Sandoz, Inc. |
Patient ventilator
|
US4098272A
(en)
*
|
1975-09-25 |
1978-07-04 |
Bio-Med Devices Inc. |
Respirator
|
US4141356A
(en)
*
|
1976-06-16 |
1979-02-27 |
Bourns, Inc. |
Respirator system and method
|
US4148312A
(en)
*
|
1976-10-08 |
1979-04-10 |
Minnesota Mining And Manufacturing Company |
Combination anesthesia and intensive care apparatus
|
US4155357A
(en)
*
|
1976-12-10 |
1979-05-22 |
Sandoz, Inc. |
Patient ventilator disconnect alarm
|
JPS5447900U
(en)
*
|
1977-09-09 |
1979-04-03 |
|
|
US4197843A
(en)
*
|
1978-04-03 |
1980-04-15 |
Minnesota Mining And Manufacturing Company |
Volume limiting ventilator
|
JPS58500390A
(en)
*
|
1981-03-26 |
1983-03-17 |
バス−エス ミユスゼリパリ スゾベツトケゼツト |
Respiratory equipment specifically used in perinatal medicine
|
DE3126207C2
(en)
*
|
1981-07-03 |
1983-11-17 |
Drägerwerk AG, 2400 Lübeck |
Timed ventilator
|
US4448192A
(en)
*
|
1982-03-05 |
1984-05-15 |
Hewlett Packard Company |
Medical ventilator device parametrically controlled for patient ventilation
|
US4459982A
(en)
*
|
1982-09-13 |
1984-07-17 |
Bear Medical Systems, Inc. |
Servo-controlled demand regulator for respiratory ventilator
|
US4702240A
(en)
*
|
1986-07-22 |
1987-10-27 |
Bear Medical Systems, Inc. |
Demand-responsive gas blending system for medical ventilator
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5111809A
(en)
*
|
1988-12-01 |
1992-05-12 |
Avstar Aerospace Corporation |
Breathing system
|
DE3900276A1
(en)
*
|
1989-01-07 |
1990-07-12 |
Draegerwerk Ag |
VENTILATOR WITH BREATHING CIRCUIT AND CONTROLLED FRESH GAS SUPPLY
|
US5086767A
(en)
*
|
1990-09-26 |
1992-02-11 |
Canadian Aging & Rehabilitation Product Development Corporation |
Ventilator for assisting the breathing of a patient
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
GB2282542B
(en)
*
|
1993-10-06 |
1997-06-25 |
Instruments & Movements Ltd |
Ventilators for promoting lung function
|
US6077533A
(en)
*
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
US5411745A
(en)
*
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
FI974148A
(en)
|
1997-11-05 |
1999-05-06 |
Instrumentarium Oy |
Method and apparatus of a breathing apparatus
|
SI2266564T1
(en)
|
1997-12-22 |
2013-07-31 |
Euro-Celtique S.A. |
Pharmaceutical oral dosage form comprising a combination of an opioid agonist and an opioid antagonist
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
EP1041968B1
(en)
|
1997-12-29 |
2004-03-03 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
AU1937099A
(en)
|
1997-12-31 |
1999-07-19 |
Alza Corporation |
Osmotic drug delivery monitoring system and method
|
TW407058B
(en)
|
1998-07-17 |
2000-10-01 |
Dev Center Biotechnology |
Oral cisapride dosage forms with an extended duration
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
CN102716101A
(en)
|
1999-10-29 |
2012-10-10 |
欧罗赛铁克股份有限公司 |
Controlled release hydrocodone formulations
|
SI1299104T1
(en)
|
2000-02-08 |
2009-10-31 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations
|
DE60135441D1
(en)
|
2000-02-08 |
2008-10-02 |
Euro Celtique Sa |
COMPOSITIONS WITH CONTROLLED RELEASE CONTAINING AN OPIOID AGONIST AND ANTAGONIST
|
EP2283829A1
(en)
|
2000-10-30 |
2011-02-16 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
EP1387673B1
(en)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Abuse-resistant controlled-release opioid dosage form
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
WO2003013433A2
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
DK1414451T3
(en)
|
2001-08-06 |
2009-08-10 |
Euro Celtique Sa |
Opioid agonist formulations with release and sequenced antagonist
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
US7387123B2
(en)
*
|
2001-11-30 |
2008-06-17 |
Viasys Manufacturing, Inc. |
Gas identification system and volumetrically correct gas delivery system
|
DE20308437U1
(en)
|
2002-04-05 |
2003-11-13 |
Euro Celtique Sa |
Matrix for delayed, consistent and independent release of drugs
|
US7771707B2
(en)
|
2004-06-12 |
2010-08-10 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
WO2005007135A1
(en)
|
2002-08-15 |
2005-01-27 |
Euro-Celtique S.A. |
Pharmaceutical compositions
|
US7267120B2
(en)
|
2002-08-19 |
2007-09-11 |
Allegiance Corporation |
Small volume nebulizer
|
AU2003270778B2
(en)
|
2002-09-20 |
2009-10-08 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
JP4865330B2
(en)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
Oral drug delivery system
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
SI1663229T1
(en)
|
2003-09-25 |
2010-08-31 |
Euro Celtique Sa |
Pharmaceutical combinations of hydrocodone and naltrexone
|
AU2004305563C1
(en)
|
2003-12-11 |
2011-07-07 |
Sunovion Pharmaceuticals Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
WO2006007351A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Squeeze controlled oral dosage form
|
AP2274A
(en)
*
|
2005-01-28 |
2011-08-19 |
Euro Celtiques Sa |
Alcohol resistant dosage forms.
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
HUE032156T2
(en)
|
2006-06-19 |
2017-09-28 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical compositions
|
EP2019101A1
(en)
*
|
2007-07-26 |
2009-01-28 |
GPC Biotech AG |
Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor
|
JP2011506319A
(en)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
Useful methods for the treatment of pain, joint inflammation symptoms, or inflammation associated with chronic diseases
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
AR074760A1
(en)
*
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
GPR120 RECEIVER AGONISTS AND USES OF THE SAME IN MEDICINES FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME.
|
CA2754853C
(en)
|
2009-03-10 |
2015-04-28 |
Euro-Celtique S.A. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
KR101572336B1
(en)
|
2010-12-22 |
2015-11-26 |
퍼듀 퍼머 엘피 |
Encased tamper resistant controlled release dosage forms
|
AU2011346758C1
(en)
|
2010-12-23 |
2015-09-03 |
Purdue Pharma L.P. |
Tamper resistant solid oral dosage forms
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
ES2851175T3
(en)
|
2013-02-05 |
2021-09-03 |
Purdue Pharma Lp |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
UA116567C2
(en)
|
2013-07-23 |
2018-04-10 |
Євро-Селтік С.А. |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
AU2015207733A1
(en)
|
2014-01-15 |
2016-07-14 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
US10201667B2
(en)
|
2015-03-26 |
2019-02-12 |
Becton, Dickinson And Company |
IV membrane attachment systems and methods
|
US10232130B2
(en)
|
2015-03-26 |
2019-03-19 |
Becton, Dickinson And Company |
Anti-run dry membrane
|
US10702689B2
(en)
|
2015-03-26 |
2020-07-07 |
Becton, Dickinson And Company |
Auto-stop vent plug
|
US10646648B2
(en)
|
2015-04-01 |
2020-05-12 |
Becton, Dickinson And Company |
IV flow management systems and methods
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
US10820833B2
(en)
|
2016-12-09 |
2020-11-03 |
Physio-Control, Inc. |
Capnograph system further detecting spontaneous patient breaths
|
WO2021188909A1
(en)
*
|
2020-03-19 |
2021-09-23 |
The Regents Of The University Of California |
Mechanical ventilator with a fixed number of orifice plates to generate constant flow paths
|